Mitochondrial cofactors in experimental Huntington's disease: Behavioral, biochemical and histological evaluation

Behavioural Brain Research

Volumn 261, Issue , 2014, Pages 345-355

  Mehrotra, Arpit ^a   Sandhir, Rajat ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Acetyl l carnitine; Alpha lipoic acid; Behavior; Huntington's disease; Mitochondria

Indexed keywords

3 NITROPROPIONIC ACID; LEVACECARNINE; THIOCTIC ACID; THIOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BEHAVIOR DISORDER; BRAIN DAMAGE; BRAIN MITOCHONDRION; COGNITIVE DEFECT; COMORBIDITY; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE MODEL; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; ELEVATED PLUS MAZE TEST; EXPERIMENTAL MODEL; EXPERIMENTAL TEST; FEMALE; FOOTPRINT TEST; FUNCTIONAL ASSESSMENT; GAIT DISORDER; HISTOPATHOLOGY; HUNTINGTON CHOREA; LATENT PERIOD; LIPID PEROXIDATION; LOCOMOTION; MENTAL TASK; MOTOR COORDINATION; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; ROTAROD TEST; T-MAZE TEST; WALKING;

2,3,5-TRIPHENYLTETRAZOLIUM CHLORIDE; 3,3′-DI-AMINOBENZIDINE; 3-NITROPROPIONIC ACID; 3-NP; ACETYL-L-CARNITINE; ALA; ALCAR; ALPHA-LIPOIC ACID; BEHAVIOR; DAB; GFAP; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; GSH; HD; HUNTINGTON'S DISEASE; MALONDIALDEHYDE; MDA; MITOCHONDRIA; TTC;

ACETYLCARNITINE; ANIMALS; ANTIOXIDANTS; BEHAVIOR, ANIMAL; BRAIN; CHROMATOGRAPHY, THIN LAYER; DISEASE MODELS, ANIMAL; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; HUNTINGTON DISEASE; LIPID PEROXIDATION; MAZE LEARNING; MOTOR ACTIVITY; NITRO COMPOUNDS; PROPIONATES; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; ROTAROD PERFORMANCE TEST; THIOCTIC ACID;

EID: 84892546294     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2013.12.035     Document Type: Article

References (64)

1. The Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
2. Lin M.T., Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006, 443:787-795.
3. Vis J.C., de Boer-van Huizen R.T., Verbeek M.M., de Waal R.M., ten Donkelaar H.J., Kremer B. 3-Nitropropionic acid induces cell death and mitochondrial dysfunction in rat corticostriatal slice cultures. Neurosci Lett 2002, 329:86-90.
4. Beal M.F., Brouillet E., Jenkins B.G., Henshaw R., Rosen B., Hyman B.T. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 1993, 13:4181-4192.
5. Johri A., Chandra A., Beal M.F. PGC-1α, mitochondrial dysfunction, and Huntington's disease. Free Radic Biol Med 2013, 62:37-46.
6. Ames B.N., Shigenaga M.K., Hagen T.M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993, 90:7915-7922.
7. Zaitone S.A., Abo-Elmatty D.M., Shaalan A.A. Acetyl-l-carnitine and α-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy. Pharmacol Biochem Behav 2012, 100:347-360.
8. Rebouche C.J. Carnitine function and requirements during the life cycle. FASEB J 1992, 6:3379-3386.
9. Barnes C.A., Markowska A.L., Ingram D.K., Kametani H., Spangler E.L., Lemken V.J., et al. Acetyl-1-carnitine. Effects on learning and memory performance of aged rats in simple and complex mazes. Neurobiol Aging 1990, 11:499-506.
10. Moini H., Packer L., Saris N.E. Antioxidant and prooxidant activities of alpha-lipoic acid and dihydrolipoic acid. Toxicol Appl Pharmacol 2002, 182:84-90.
11. Liu J., Head E., Gharib A.M., Yuan W., Ingersoll R.T., Hagen T.M., et al. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-l-carnitine and/or R-alpha-lipoic acid. Proc Natl Acad Sci USA 2002, 99:2356-2361.
12. Milgram N.W., Araujo J.A., Hagen T.M., Treadwell B.V., Ames B.N. Acetyl-l-carnitine and alpha-lipoic acid supplementation of aged beagle dogs improves learning in two landmark discrimination tests. FASEB J 2007, 21:3756-3762.
13. Liu J. The effects and mechanisms of mitochondrial nutrient alpha-lipoic acid on improving age-associated mitochondrial and cognitive dysfunction: an overview. Neurochem Res 2008, 33:194-203.
14. Cirillo G., Maggio N., Bianco M.R., Vollono C., Sellitti S., Papa M. Discriminative behavioral assessment unveils remarkable reactive astrocytosis and early molecular correlates in basal ganglia of 3-nitropropionic acid subchronic treated rats. Neurochem Int 2010, 56:152-160.
15. Frussa-Filho R., Abílio V.C., Bergamo M., Palermo-Neto J. Behavioural subsensitivity induced by long-term administration of a low dose of haloperidol to rats. J Pharm Pharmacol 1997, 49:412-415.
16. Masoud A., Kiran R., Sandhir R. Modulation of dopaminergic system and neurobehavioral functions in delayed neuropathy induced by organophosphates. Toxicol Mech Methods 2011, 21:1-5.
17. Rozas G., López-Martín E., Guerra M.J., Labandeira-García J.L. The overall rod performance test in the MPTP-treated-mouse model of Parkinsonism. J Neurosci Methods 1998, 83:165-175.
18. Itoh J., Nabeshima T., Kameyama T. Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice. Eur J Pharmacol 1991, 194:71-76.
19. Lione L.A., Carter R.J., Hunt M.J., Bates G.P., Morton A.J., Dunnett S.B. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J Neurosci 1999, 19:10428-10437.
20. Kamboj S.S., Chopra K., Sandhir R. Neuroprotective effect of N-acetylcysteine in the development of diabetic encephalopathy in streptozotocin-induced diabetes. Metab Brain Dis 2008, 23:427-443.
21. Dhanda S., Kaur S., Sandhir R. Preventive effect of N-acetyl-l-cysteine on oxidative stress and cognitive impairment in hepatic encephalopathy following bile duct ligation. Free Radic Biol Med 2013, 56:204-215.
22. Roberts J.C., Francetic D.J. The importance of sample preparation and storage in glutathione analysis. Anal Biochem 1993, 211:183-187.
23. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193:265-275.
24. Nam E., Lee S.M., Koh S.E., Joo W.S., Maeng S., Im H.I., et al. Melatonin protects against neuronal damage induced by 3-nitropropionic acid in rat striatum. Brain Res 2005, 1046:90-96.
25. Kiernan J.A. Histological and histochemical methods 2008, Scion Publishing Ltd., Oxfordshire, UK. 4th ed.
26. Garnier P., Bertrand N., Demougeot C., Prigent-Tessier A., Marie C., Beley A. Chemical preconditioning with 3-nitropropionic acid: lack of induction of neuronal tolerance in gerbil hippocampus subjected to transient forebrain ischemia. Brain Res Bull 2002, 58:33-39.
27. Bayram-Weston Z., Jones L., Dunnett S.B., Brooks S.P. Light and electron microscopic characterization of the evolution of cellular pathology in the R6/1 Huntington's disease transgenic mice. Brain Res Bull 2012, 88:104-112.
28. Sandhir R., Mehrotra A. Quercetin supplementation is effective in improving mitochondrial dysfunctions induced by 3-nitropropionic acid: implications in Huntington's disease. Biochim Biophys Acta 2013, 1832:421-430.
29. Fernagut P.O., Diguet E., Labattu B., Tison F. A simple method to measure stride length as an index of nigrostriatal dysfunction in mice. J Neurosci Methods 2002, 113:123-130.
30. Vis J.C., Verbeek M.M., De Waal R.M., Ten Donkelaar H.J., Kremer H.P. 3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum. Neuropathol Appl Neurobiol 1999, 25:513-521.
31. Kendall A.L., Hantraye P., Palfi S. Striatal tissue transplantation in non-human primates. Prog Brain Res 2000, 127:381-404.
32. Grünewald T., Beal M.F. Bioenergetics in Huntington's disease. Ann N Y Acad Sci 1999, 893:203-213.
33. Brouillet E., Jacquard C., Bizat N., Blum D. 3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease. J Neurochem 2005, 95:1521-1540.
34. Sun M., Qian F., Shen W., Tian C., Hao J., Sun L., et al. Mitochondrial nutrients stimulate performance and mitochondrial biogenesis in exhaustively exercised rats. Scand J Med Sci Sports 2012, 22:764-775.
35. Barquero-Jiménez M.S., Gómez-Tortosa E. Cognitive disorders in patients with Huntington's disease. Rev Neurol 2001, 32:1067-1071.
36. Becker S., Lim J. A computational model of prefrontal control in free recall: strategic memory use in the California Verbal Learning Task. J Cogn Neurosci 2003, 15:821-832.
37. Nishino H., Hida H., Kumazaki M., Shimano Y., Nakajima K., Shimizu H., et al. The striatum is the most vulnerable region in the brain to mitochondrial energy compromise: a hypothesis to explain its specific vulnerability. J Neurotrauma 2000, 17:251-260.
38. Sandhir R., Sood A., Mehrotra A., Kamboj S.S. N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease. Neurodegener Dis 2012, 9:145-157.
39. Hagen T.M., Moreau R., Suh J.H., Visioli F. Mitochondrial decay in the aging rat heart: evidence for improvement by dietary supplementation with acetyl-l-carnitine and/or lipoic acid. Ann N Y Acad Sci 2002, 959:491-507.
40. Gorini A., D'Angelo A., Villa R.F. Energy metabolism of synaptosomal subpopulations from different neuronal systems of rat hippocampus: effect of l-acetylcarnitine administration in vivo. Neurochem Res 1999, 24:617-624.
41. Ando S., Tadenuma T., Tanaka Y., Fukui F., Kobayashi S., Ohashi Y., et al. Enhancement of learning capacity and cholinergic synaptic function by carnitine in aging rats. J Neurosci Res 2001, 66:266-271.
42. Suh J.H., Moreau R., Heath S.H., Hagen T.M. Dietary supplementation with (R)-alpha-lipoic acid reverses the age-related accumulation of iron and depletion of antioxidants in the rat cerebral cortex. Redox Rep 2005, 10:52-60.
43. Milgram N.W., Head E., Zicker S.C., Ikeda-Douglas C., Murphey H., Muggenberg B.A., et al. Long-term treatment with antioxidants and a program of behavioral enrichment reduces age-dependent impairment in discrimination and reversal learning in beagle dogs. Exp Gerontol 2004, 39:753-765.
44. Benchoua A., Trioulier Y., Zala D., Gaillard M.C., Lefort N., Dufour N., et al. Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated huntingtin. Mol Biol Cell 2006, 17:1652-1663.
45. Aksenova M., Butterfield D.A., Zhang S.X., Underwood M., Geddes J.W. Increased protein oxidation and decreased creatine kinase BB expression and activity after spinal cord contusion injury. J Neurotrauma 2002, 19:491-502.
46. Atif F., Yousuf S., Agrawal S.K. S-allyl l-cysteine diminishes cerebral ischemia-induced mitochondrial dysfunctions in hippocampus. Brain Res 2009, 1265:128-137.
47. Yang Z., Hancock W.S. Monitoring glycosylation pattern changes of glycoproteins using multi-lectin affinity chromatography. J Chromatogr A 2005, 1070:57-64.
48. Di-Giacomo C., Latteri F., Fichera C., Sorrenti V., Campisi A., Castorina C., et al. Effect of acetyl-l-carnitine on lipid peroxidation and xanthine oxidase activity in rat skeletal muscle. Neurochem Res 1993, 18:1157-1162.
49. Arivazhagan P., Panneerselvam C. Effect of dl-alpha-lipoic acid on tissue nucleic acid contents in aged rats. Pharmacol Res 2000, 42:223-226.
50. Dinçer Y., Telci A., Kayali R., Yilmaz I.A., Cakatay U., Akçay T. Effect of alpha-lipoic acid on lipid peroxidation and anti-oxidant enzyme activities in diabetic rats. Clin Exp Pharmacol Physiol 2002, 29:281-284.
51. Steele M.L., Robinson S.R. Reactive astrocytes give neurons less support: implications for Alzheimer's disease. Neurobiol Aging 2012, 33(423):e1-e13.
52. Dringen R., Kussmaul L., Gutterer J.M., Hirrlinger J., Hamprecht B. The glutathione system of peroxide detoxification is less efficient in neurons than in astroglial cells. J Neurochem 1999, 72:2523-2530.
53. Sandhir R., Mehrotra A., Kamboj S.S. Lycopene prevents 3-nitropropionic acid-induced mitochondrial oxidative stress and dysfunctions in nervous system. Neurochem Int 2010, 57:579-587.
54. Mantovani V., Salardi S., Cerreta V., Bastia D., Cenci M., Ragni L., et al. Identification of eight novel glucokinase mutations in Italian children with maturity-onset diabetes of the young. Hum Mutat 2003, 22:338-340.
55. Calabrese V., Colombrita C., Sultana R., Scapagnini G., Calvani M., Butterfield D.A., et al. Redox modulation of heat shock protein expression by acetylcarnitine in aging brain: relationship to antioxidant status and mitochondrial function. Antioxid Redox Signal 2006, 8:404-416.
56. Prahalathan C., Selvakumar E., Varalakshmi P., Kumarasamy P., Saravanan R. Salubrious effects of lipoic acid against adriamycin-induced clastogenesis and apoptosis in Wistar rat bone marrow cells. Toxicology 2006, 222:225-232.
57. Wüllner U., Young A.B., Penney J.B., Beal M.F. 3-Nitropropionic acid toxicity in the striatum. J Neurochem 1994, 63:1772-1781.
58. Dykens J.A. Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated Ca and Na: implications for neurodegeneration. J Neurochem 1994, 63:584-591.
59. Beal M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses. Ann Neurol 1992, 31:119-130.
60. +-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease. J Neurochem 2008, 104:420-434.
61. Reynolds D.S., Carter R.J., Morton A.J. Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease. J Neurosci 1998, 18:10116-10127.
62. Gopinath K., Sudhandiran G. Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway. Neuroscience 2012, 227:134-143.
63. Duran-Vilaregut J., Manich G., Del Valle J., Camins A., Pallàs M., Vilaplana J., et al. Expression pattern of ataxia telangiectasia mutated (ATM), p53, Akt, and glycogen synthase kinase-3β in the striatum of rats treated with 3-nitropropionic acid. J Neurosci Res 2012, 90:1803-1813.
64. Ferger A.I., Campanelli L., Reimer V., Muth K.N., Merdian I., Ludolph A.C., et al. Effects of mitochondrial dysfunction on the immunological properties of microglia. J Neuroinflamation 2010, 7:45-50.